Insiders · BTX

BTX insider transactions

BlackRock Technology and Private Equity Term Trust (BTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

BTX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at BlackRock Technology and Private Equity Term Trust, latest first. Follow anyone to get their next filing.

• Francis C. MahoneyDirector, since September 2026
• Charles ParkChief Compliance Officer, since August 2026
• Steven Reid MengePortfolio Manager, since February 2025
• Tony KimPortfolio Manager, since February 2025
• Robert W FairbairnDirector+$205K-$476K
• Saba Capital Management, L.P.10% owner, since September 2023+$276M
• Stephen Thomas MinarVice President, since May 2025
• Philip Henry RuvinskyPortfolio Manager+$367K
• Kyle McClementsPortfolio Manager+$14.6K
• Christopher AccettellaPortfolio Manager
• Arthur Philip SteinmetzDirector, since September 2023
• Aaron David WassermanOfficer, since July 2023
• William Stuart BroadbentInsider+$62.4K
• John PerlowskiOfficer, Director+$98.3K
• Jonathan DiorioOfficer+$182K
• Misha LozovikInsider, since June 2021+$383K
• Lorenzo FloresDirector, since July 2021
• Stayce D. HarrisDirector, since June 2021
• James Phillip HollomanDirector, since June 2021
• Catherine A. LynchDirector, since May 2021
• Michael J CastellanoDirector, since May 2021

Recent Form 3, 4, and 5 filings for BTX

• 52d
  SEC Form 3 filed by new insider Mahoney Francis C.

  3 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 95d
  SEC Form 3 filed by new insider Park Charles

  3 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 278d
  SEC Form 4 filed by Portfolio Manager Menge Steven Reid

  4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 278d
  SEC Form 4 filed by Portfolio Manager Kim Tony

  4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 321d
  Director Fairbairn Robert W sold $143,027 worth of shares (21,937 units at $6.52), closing all direct ownership in the company (SEC Form 4)

  4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 486d
  Large owner Saba Capital Management, L.P. disposed of $454,458,709 worth of shares (60,675,395 units at $7.49) (SEC Form 4)

  4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 541d
  New insider Minar Stephen Thomas claimed ownership of 1,967 shares (SEC Form 3)

  3 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 996d
  SEC Form 3 filed by new insider Cicala Peter

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1040d
  SEC Form 4 filed by Luther Sanjeev

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1040d
  SEC Form 4 filed by Clarke Dorothy J

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1040d
  SEC Form 3 filed by new insider Luther Sanjeev

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1055d
  SEC Form 4 filed by Cherington Charles

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1056d
  SEC Form 4 filed by Freebird Partners Lp

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1091d
  SEC Form 3 filed by new insider Bristol James Arthur

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1164d
  SEC Form 3 filed by new insider Clarke Dorothy J

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1171d
  SEC Form 4 filed by Cherington Charles

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1186d
  SEC Form 4 filed by Binder Brant

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1186d
  SEC Form 4 filed by Wagner Richard W

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1209d
  SEC Form 4 filed by Binder Brant

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1209d
  SEC Form 4 filed by Wagner Richard W

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1210d
  SEC Form 4 filed by Freebird Partners Lp

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1216d
  SEC Form 3 filed by new insider Wagner Richard W

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1216d
  SEC Form 3 filed by new insider Binder Brant

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1234d
  SEC Form 4 filed by Gurrola Sandra M

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1314d
  SEC Form 3: New insider Freebird Partners Lp claimed ownership of 272,582 shares

  3 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1395d
  SEC Form 4 filed by Angel Matthew

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1433d
  SEC Form 4: Cherington Charles bought $858,560 worth of shares (261,756 units at $3.28), increasing direct ownership by 89% to 556,465 units

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1433d
  SEC Form 4: Singer Nicholas Jason bought $929,178 worth of shares (283,286 units at $3.28)

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1434d
  SEC Form 4: Halpern John D bought $1,101,818 worth of shares (335,920 units at $3.28)

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1509d
  SEC Form 4: Sidhu Roger converted options into 20,163 shares

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1558d
  SEC Form 4 filed by Cherington Charles

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1558d
  SEC Form 4 filed by Angel Matthew

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1558d
  SEC Form 4 filed by Singer Nicholas Jason

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1558d
  SEC Form 4 filed by Fiore Gregory

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1558d
  SEC Form 4 filed by Wexler William A.

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1593d
  SEC Form 4: Damour Kevin converted options into 17,573 shares and covered exercise/tax liability with 6,077 shares

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1599d
  SEC Form 4: Gurrola Sandra M converted options into 8,750 shares and covered exercise/tax liability with 3,586 shares, increasing direct ownership by 63% to 13,367 units

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1615d
  SEC Form 3: New insider Singer Nicholas Jason claimed ownership of 2,095,000 shares

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1615d
  SEC Form 3 filed by new insider Wexler William A.

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1615d
  SEC Form 3 filed by new insider Fiore Gregory

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1616d
  SEC Form 4 filed by Jackson Andrew C.

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1621d
  SEC Form 3 filed by new insider Jackson Andrew C.

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1621d
  SEC Form 3: New insider Angel Matthew claimed ownership of 3,489,666 shares

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1697d
  SEC Form 4 filed by Gurrola Sandra M (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1697d
  SEC Form 4 filed by Damour Kevin (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1697d
  SEC Form 4 filed by Sidhu Roger (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1697d
  SEC Form 4 filed by Sial Jay (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1697d
  SEC Form 4 filed by Federoff Howard J. (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1699d
  SEC Form 4 filed by Gurrola Sandra M

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1699d
  SEC Form 4 filed by Damour Kevin

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1699d
  SEC Form 4 filed by Federoff Howard J.

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1699d
  SEC Form 4 filed by Sidhu Roger

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1699d
  SEC Form 4 filed by Sial Jay

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1754d
  SEC Form 4 filed by Enright Erin S.

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1754d
  SEC Form 4 filed by Redman Heather B

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1754d
  SEC Form 3 filed by new insider Enright Erin S.

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1754d
  SEC Form 3 filed by new insider Redman Heather B

  3 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1794d
  SEC Form 4 filed by Mohr Erich

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1794d
  SEC Form 4: Cherington Charles acquired 92 shares, increasing direct ownership by 0.00% to 5,894,193 units

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1794d
  SEC Form 4 filed by Greenwood Luba

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)